Volunteer for NIAID-funded clinical studies related to emerging infectious diseases on ClinicalTrials.gov.
NIAID scientists have begun studies of an emerging coronavirus responsible for at least two deaths in the Middle East.
The term "emerging infectious diseases" (EIDs) includes newly emerging infections, such as SARS; re-emerging/resurging infections, such as influenza and West Nile virus; and deliberately emerging infections, such as those caused by microbes used for bioterror.
NIAID supports and conducts research on basic and applied aspects of host, pathogen, and environmental factors that influence disease emergence and transmission as well as on the development of diagnostics, vaccines, and therapeutics necessary to detect and control infectious diseases. NIAID also supports clinincal research on emerging, re-emerging, and intractable infectious diseases.
Additionally, NIAID supports training programs to maintain and develop the national and international scientific expertise required to respond to future health threats.
The NIAID divisions that support EID research are
Last Updated March 19, 2010